BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 7129248)

  • 1. [Effects of (E)-1-[bis (4-fluorophenyl)methyl]-4-(3-phenyl-2-propenyl) piperazine dihydrochloride(flunarizine) on cerebral circulation].
    Kubo K; Karasawa A; Yamada K; Nito M; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):383-400. PubMed ID: 7129248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of flunarizine on cerebral venous outflow and cerebral oxygen consumption].
    Kubo K; Jageneau T
    Nihon Yakurigaku Zasshi; 1982 Jun; 79(6):529-41. PubMed ID: 7129242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilating effect of flunarizine in anesthetized dogs.
    Kato H; Kurihara J; Ishii K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):257-63. PubMed ID: 7224725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental studies on the effect of Aligeron on the cerebral circulation.
    Vlahov V; Nikolov R; Nikolova M
    Acta Physiol Pharmacol Bulg; 1980; 6(2):65-9. PubMed ID: 7435216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of suloctidil on the dynamics of the peripheral artery of the dog].
    Horii D; Ishibashi A; Sano F
    Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):67-78. PubMed ID: 6311700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and haemodynamic effects of intravenous administrations of flunarizine in closed-chest anaesthetized mongrel dogs.
    Kubo K; Van de Water A; Wouters L; Xhonneux R; Reneman RS
    Arzneimittelforschung; 1984; 34(4):434-9. PubMed ID: 6430305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of flunarizine on nystagmus and cochlear blood flow].
    Shiozaki S; Kubo K; Shuto K; Nakamizo N
    Nihon Yakurigaku Zasshi; 1982 Dec; 80(6):429-39. PubMed ID: 7160792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aligeron on the cerebral venous outflow and cerebrospinal fluid pressure in dogs.
    Nikolova M; Nikolov R; Hadjiev D; Yancheva S
    Methods Find Exp Clin Pharmacol; 1981; 3(4):213-6. PubMed ID: 7278433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular pharmacology of cinepazide, a new cerebral vasodilator (author's transl)].
    Akashi A; Hirohashi M; Suzuki I; Shibamura S; Kasahara A
    Nihon Yakurigaku Zasshi; 1979 Jul; 75(5):507-16. PubMed ID: 540882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of aligeron on the resistance of the cerebral and peripheral blood vessels.
    Nikolov R; Vlahov V; Taskov M
    Acta Physiol Pharmacol Bulg; 1980; 6(3):54-9. PubMed ID: 7282382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a new vasodilator (flunarizine) on the cerebral circulation.
    Toyoda M; Takagi S; Seki T; Takeoka T; Goto F
    J Neurol Sci; 1975 Jul; 25(3):371-5. PubMed ID: 1159451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of suloctidil on cerebral venous outflow in the dog (author's transl)].
    Nishi H; Ishibashi A; Horii D
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):117-26. PubMed ID: 6274771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and hemodynamic studies on flunarizine.
    Gulati N; Huggel H; Gulati OP
    Gen Pharmacol; 1983; 14(1):203-6. PubMed ID: 6826036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flunarizine, cerebral blood flow and reversion of experimental atherosclerosis in rabbit.
    Favalli L; Lanza E; Rozza Dionigi A; Assogna G; Goggi D; Ricevuti G
    Drugs Exp Clin Res; 1985; 11(12):845-50. PubMed ID: 3836114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsive properties of cinnarizine and flunarizine in rats and mice.
    Desmedt LK; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1975 Sep; 25(9):1408-13. PubMed ID: 1242663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrovascular effects of YC-93, a new vasodilator, in dogs, monkeys and human patients.
    Takenaka T; Handa J
    Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):1-11. PubMed ID: 33121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective vasodilatory effect of dipfluzine on vertebral artery in anesthetized dogs.
    Wang YL; He RR
    Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):124-7. PubMed ID: 8352003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Agents to improve cerebrovascular circulation and cerebral metabolism--flunarizine].
    Kurihara J; Kato H
    Nihon Rinsho; 1985 Feb; 43(2):402-5. PubMed ID: 3889415
    [No Abstract]   [Full Text] [Related]  

  • 20. Excretion and metabolism of flunarizine in rats and dogs.
    Meuldermans W; Hendrickx J; Hurkmans R; Swysen E; Woestenborghs R; Lauwers W; Heykants J
    Arzneimittelforschung; 1983; 33(8):1142-51. PubMed ID: 6685491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.